ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HHBT HH Biotechnology Holdings Company (CE)

0.0003
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
HH Biotechnology Holdings Company (CE) USOTC:HHBT OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0003 0.00 01:00:00

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

09/03/2017 7:37pm

Edgar (US Regulatory)


 

 
 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
 
 
 
 
FORM 15
 
 
 
 
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12 (g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES ACT OF 1934.
 
 
Commission File Number 
0-23015
 
 
HH Biotechnology Holdings Company
 
 
(Exact name of registrant as specified in its charter)
 
 
 
      
 
 
 
C Site 25-26F Presidential Bldg.,
No. 69 Heping North Street,
Heping District, Shenyang 110003, PRC
 
 
 
0086-24-22813888
 
 
 
(Address, including zip code, and telephone number, including
 
 
 
 
area code, of registrant’s principal executive offices)
 
 
 
 
Common Stock, par value $0.001 per share (“Common Stock”)
 
 
(Title of each class of securities covered by this Form)
 
 
 
None
 
 
(Title of all other classes of securities for which a duty to file reports
 
 
under section 13(a) or 15(d) remains)
 
 
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
X
 
 
Rule 12g-4(a)(2)
 
 
 
Rule 12h-3(b)(1)(i)
 
 
 
Rule 12h-3(b)(1)(ii)
 
 
 
Rule 15d-6
 
 
 
Rule 15d-22(b)
 
 
 
Approximate number of holders of record as of the certification or notice date: 151
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Caspian Services, Inc. has caused this
certification/notice to be signed on its behalf by the undersigned duly authorized person
 
 
Date:
February 15, 2017
 
By:
/s/ Sheng Jiang
 
Sheng Jiang
 
Chief Executive Officer
 
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
 

 

1 Year HH Biotechnology (CE) Chart

1 Year HH Biotechnology (CE) Chart

1 Month HH Biotechnology (CE) Chart

1 Month HH Biotechnology (CE) Chart

Your Recent History